Directory

>

Andrew Obenshain

avatar

Andrew Obenshain

Chief Executive Officer | bluebird bio

Cambridge, Massachusetts, United States

View contact details (it's free)

Andrew Obenshain

Summary

Andrew Obenshain is a seasoned biotech business leader with a strong commitment to advancing therapies for rare diseases. Currently serving as the CEO of bluebird bio, he leverages his extensive experience in the pharmaceutical industry to lead cross-functional teams and drive product launches. With a background that includes significant roles at Sanofi and Shire, Andrew has honed his skills in strategy development and operational excellence. He holds an MBA from Northwestern University's Kellogg School of Management and a BA in Biology from Dartmouth College. His passion for improving patient outcomes is matched by his strategic vision for the future of biotechnology. Andrew's leadership style is characterized by collaboration and innovation, making him a key player in the life sciences sector. He has a track record of success in both domestic and international markets, particularly in Europe.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Startup Experience

Corporate Experience

Consulting Experience

Andrew Obenshain

Work Experience

company logo

Chief Executive Officer at

bluebird bio

November 2021 - Present

company logo

President SGD Business Unit at

bluebird bio

January 2021 - November 2021

company logo

Chief of Wings at

bluebird bio

January 2020 - January 2021

company logo

SVP, Head of Europe at

bluebird bio

December 2016 - January 2020

company logo

General Manager France & Benelux at

SHIRE LIMITED

September 2015 - September 2016

company logo

Head of Integrate Care Center of Excellence (acting), and VP Portfolio Strategy Integrated Care at

Sanofi

July 2014 - July 2015

company logo

Vice President Operations Support and Strategy at

Sanofi

June 2012 - June 2014

💼

Director, Oncology Commercial Operations at

SANOFI SAGLIK URUNLERI LIMITED SIRKETI

August 2011 - May 2012

company logo

Director of US Marketing, Campath and Leukine at

SANOFI-AVENTIS AUSTRALIA PTY LTD

May 2009 - July 2011

company logo

Associate Director Oncology Business Development at

SANOFI-AVENTIS AUSTRALIA PTY LTD

June 2007 - April 2009

company logo

Marketing Associate at

Merck

November 2005 - May 2007

company logo

Pharmaceutical Sales at

Merck

August 2004 - October 2005

company logo

Associate at

Scale Venture Partners

June 2000 - June 2002

company logo

Associate at

Health Advances

January 1996 - January 2000

Logos provided by Logo.dev

Andrew Obenshain

Education

Kellogg School of Management, Mba

January 2002 - January 2004

Dartmouth College, Ba

January 1992 - January 1996

Frequently Asked Questions about Andrew Obenshain

What is Andrew Obenshain email address?

Andrew Obenshain's primary email address is **********@bluebirdbio.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Andrew Obenshain work for?

Andrew Obenshain is a Chief Executive Officer at bluebird bio, a company specializing in Commercial physical research.

Where Andrew Obenshain graduated from?

Andrew Obenshain holds a degree in from Kellogg School of Management.

How can I directly contact Andrew Obenshain?

To contact Andrew Obenshain directly, you can use the email address **********@bluebirdbio.com. Complete contact information is available upon registration with Muraena.

Who is Andrew Obenshain?

Andrew Obenshain is a seasoned biotech business leader with a strong commitment to advancing therapies for rare diseases. Currently serving as the CEO of bluebird bio, he leverages his extensive experience in the pharmaceutical industry to lead cross-functional teams and drive product launches. With a background that includes significant roles at Sanofi and Shire, Andrew has honed his skills in strategy development and operational excellence. He holds an MBA from Northwestern University's Kellogg School of Management and a BA in Biology from Dartmouth College. His passion for improving patient outcomes is matched by his strategic vision for the future of biotechnology. Andrew's leadership style is characterized by collaboration and innovation, making him a key player in the life sciences sector. He has a track record of success in both domestic and international markets, particularly in Europe.

Andrew`s contact details

mail

**********@bluebirdbio.com

Colleagues

avatar
Sarah Alspach

Senior Vice President, External Affairs

avatar
Sarah Arbes

Head Of Federal Affairs And Policy

avatar
Stephanie Scarcella

Senior Manager, Administrative Services - Offices of the Chief Executive Officer and People and Culture

avatar
Anne Kantardjieff

Vice President, Manufacturing

Ravi Singh

VP, Market Access, Advocacy & Policy

avatar
Richard Colvin

Chief Medical Officer, Head of R&D

Leslie Wilder

VP - Regulatory Science

avatar
Scott Shoemaker

SVP, Technical Operations

avatar
Karen Kurti

Chief Compliance Officer

avatar
Kasra Kasraian

Senior Vice President, Technical Development & Operations

View Contact details (it's free)
Request Profile Removal